Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (47 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Oct 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quant Flexi Cap Fund |
|---|---|
| 20 Oct 2008 | ₹100.00 |
| 16 Apr 2010 | ₹139.27 |
| 11 Oct 2011 | ₹85.76 |
| 05 Apr 2013 | ₹69.43 |
| 30 Sep 2014 | ₹112.55 |
| 26 Mar 2016 | ₹118.03 |
| 20 Sep 2017 | ₹193.30 |
| 16 Mar 2019 | ₹183.80 |
| 09 Sep 2020 | ₹203.40 |
| 06 Mar 2022 | ₹374.81 |
| 31 Aug 2023 | ₹497.03 |
| 23 Feb 2025 | ₹622.60 |
| 20 Aug 2026 | ₹778.09 |
| Metric | quant · Regular · IDCW NAV ₹78.09 Very High risk ★★★☆☆ | Category median Flexi Cap Fund · 47 funds |
|---|---|---|
| +14.25% | +1.86% | |
| +16.24% | +11.07% | |
| +15.53% | +8.68% | |
| +18.37% | +5.89% | |
| +12.19% | +10.09% | |
| +14.59% | — | |
| +13.54% | +13.05% | |
| +14.86% | +11.30% | |
| +14.35% | +6.14% | |
| Risk | ||
| 16.78% | 14.74% | |
| 0.58 | 0.29 | |
| 0.80 | 0.39 | |
| -65.97% | -33.63% | |
| Nifty 500 | — | |
| +3.79% | -0.84% | |
| 1.15 | 0.98 | |
| 123.9% | 96.3% | |
| 113.5% | 102.5% | |
| 2.20% | 2.15% | |
| ₹6,713Cr | ₹3,777Cr | |
| 1.00% | — | |
| None | — | |
| ₹250 | — | |
| ₹5.00K | — | |
| 0% | 37% | |
| Sanjeev Sharma | — | |
| 20 Oct 2008 | — | |
| 27 | — | |
| 60.1% | — | |
| 1.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.